Trial NCT04326790
Publication Deftereos S, JAMA, 2020
Primary outcome on the report: The coprimary end points of the biochemical phase were the difference in maximal high-sensitivity cardiac troponin (hs cTn) levels between the 2 groups and the time for C-reactive protein to reach levels greater than 3 times the upper reference limit